{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:54:42Z","timestamp":1760043282059},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.clinthera.2009.03.011","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T08:28:42Z","timestamp":1240475322000},"page":"580-584","source":"Crossref","is-referenced-by-count":9,"title":["Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Angelo","family":"Caruso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.03.011_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: Definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2009.03.011_bib2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: The reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2009.03.011_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clindermatol.2004.06.012","article-title":"Life-threatening acute adverse cutaneous drug reactions","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clinthera.2009.03.011_bib4","series-title":"Sleisenger & Fordtran's Gastrointestinal and Liver Disease","first-page":"1819","year":"2006"},{"key":"10.1016\/j.clinthera.2009.03.011_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clinthera.2009.03.011_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clindermatol.2005.02.001","article-title":"Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: The dilemma of classification","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clinthera.2009.03.011_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.clinthera.2009.03.011_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/archderm.132.11.1315","article-title":"Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities","volume":"132","author":"Callot","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clinthera.2009.03.011_bib9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/clinchem\/46.12.2027","article-title":"Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2009.03.011_bib10","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1067\/mai.2000.106156","article-title":"Understanding drug allergies","volume":"105","author":"Gruchalla","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2009.03.011_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: General considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.03.011_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2009.03.011_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.2005.06429.x","article-title":"The usefulness of skin tests to prove drug hypersensitivity","volume":"152","author":"Lammintausta","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinthera.2009.03.011_bib14","first-page":"161","article-title":"Hypersensitivity reactions to chemotherapy drugs","volume":"15","author":"D\u00e1vila Gonz\u00e1lez","year":"2000","journal-title":"Alergol Inmunol Clin"},{"key":"10.1016\/j.clinthera.2009.03.011_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00256155","article-title":"Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone","volume":"16","author":"Dorr","year":"1986","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:04:49Z","timestamp":1710277489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0149291809000861"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.03.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}